Actuarial
  • Research and White Papers
  • July 2025

Clearing the Fog: How model choice affects mortality projections

By
  • Thomas Honeywell
  • Annie Girard
Skip to Authors and Experts
Flashlight through the fog
In Brief

An RGA analysis comparing the Canadian Institute of Actuaries (CIA) model and a Canadian calibration of the 2019 Continuous Mortality Investigation (CMI) mortality improvement model highlights the significant impact the choice of a model has on mortality projections.

Key takeaways

  • Modeling future mortality improvement comes with a high level of uncertainty, making it one of the most challenging assumptions for an actuary to determine.    
  • An RGA analysis reveals how different mortality models, even when both are based on the Age-Period-Cohort Improvement (APCI) model, can lead to materially different projections of future mortality improvements. 
  • The CIA model produces higher life expectancies than our calibration of the CMI model, and virtually every aspect considered in the analysis – initial rate, projection from initial rate to long-term rate, long-term rate, and treatment of ages 90-plus – contributes to this.

 

Methodology and definitions 

  1. The Canadian Institute of Actuaries (CIA) published a new mortality improvement scale in April 2024. It is based on a stochastic Age-Period-Cohort Improvement (APCI) model. 
  2. The Institute and Faculty of Actuaries’ Continuous Mortality Investigation (CMI) model is a mortality improvement model that is produced annually. The CMI_2019 model, released in March 2020, is also an APCI model.  
  3. The CMI model is designed for use in the UK and its parameters have been set accordingly. In this analysis, we calibrate it to Canada by changing the input population data and making an adjustment to the smoothing parameters. This is not equivalent to a CMI model designed for use in Canada, but it is sufficient for our analysis.
  4. The APCI model is quite complex, and it is not immediately clear how different parameters will impact the output.   
  5. In this analysis, we compare the CIA and CMI_2019 models to explore different parameterizations of the APCI model.  
  6. When we refer to the CIA model, we refer to the scale published in April 2024. When we refer to the CMI model, we refer to the CMI_2019 model fitted to Canadian Human Mortality Database (HMD) data and the long-term rate (LTR) set to equal the LTR in the CIA model. The decision to use CMI_2019 is to make it consistent with the CIA model, which also uses data up to 2019 and makes no allowance for the effects of the COVID-19 pandemic. The core CMI model has no default LTR, as this is left to the user, hence the decision to use the CIA LTR. 
  7. Note that the CIA did not publish its model, and we have not attempted to reproduce it exactly. Instead, we have used an adapted version of the more user-friendly CMI model as a proxy. We believe this simplification is appropriate for this analysis, which is simply meant to illustrate the impact of different modeling choices. 
  8. More recent CMI models exist. However, we do not comment on them here, as we are simply focusing on different parameters of the APCI model and not on the latest views of the CMI.  
  9. Both models are explained in more details in the CIA report1  and CMI working paper 129 and the supplement, CMI_2019 v01 methods.2 Note that the CMI paper is available only to CMI subscribers.  

Overview 

For this summary analysis, we have not delved into the full technical details of each model. Instead, we have focused on four key aspects of the models. These are:  

  • Initial rate 
  • Projection from initial rate to LTR 
  • LTR 
  • Treatment of ages 90+ 

The waterfall charts below (Figures 1A and 1B) move from CMI_2019 to the CIA model, covering three of the items mentioned above. The LTR does not feature on this chart because we have used the CIA LTR in the CMI model.

 

 

The waterfall charts show how the life expectancy for a 65-year-old varies as we move from the CMI model to the CIA model. The components of the APCI model are linked, and the impact associated with each step would vary if these steps were taken in a different order. However, the waterfalls are still useful to show how different components drive the difference between the CIA and CMI models. They show that the CIA model produces higher life expectancies than the CMI model, and almost every aspect considered contributes to this. 

Initial rate 

The initial rate is the rate of improvement in the last year of known data, the jumping-off year. It is composed of age, period, and cohort components and follows this formula: 

The level of the initial rate influences the overall rate of improvement in the future projection. The breakdown of the rate among age, period, and cohort components influences how the rates will vary based on an individual’s year of birth and age. To derive the initial rate, the APCI model is fitted to known data. The age, period, and cohort improvement components are then backed out from this model. The initial rate from our analysis was then compared to the initial rates from the CIA scale. (Figures 2A and 2B)*  

 

*The 2020 improvement rate is a good proxy for the 2019 initial rate. The CIA 2019 improvement rate is based on the historical mortality rate and does not represent the initial rate of the model.  

 

Improvements by age are smoother under the CMI model than the CIA scale, which may feel more intuitive when projecting this rate into the future. On the other hand, it is likely that the CIA model will more closely reflect recent experience, and we may only expect the mortality rates to be smooth in the future projection, not the improvement rates.  

The CIA initial rate is higher at older ages than the CMI’s. This contributes to the higher life expectancies projected by using the CIA initial rate.  

The table below outlines the different input parameters used to derive the initial rate in each model. 

Projection from the initial rate to the LTR 

Both models project the initial rate from the jumping-off year (2019) toward an LTR at the end of a convergence period.  Multiple parameters in the model influence the shape and length of the convergence. The key ones are the direction of travel (DT), which is the rate of change of the improvements just after the jumping-off point, and the convergence period, which is the number of years taken to reach the LTR. The age, period, and cohort components can each have different DTs and convergence periods.  

The graphs below show how the future projection differs for different combinations of DT and convergence period (conv), using various CIA and CMI parameters (Figures 3A and 3B). 

 

It is clear the choice of parameter can greatly influence the future projection. Table 2 describes the convergence and DT parameters.  

Long-term rate (LTR) 

The CIA set an LTR by projecting their stochastic model forward using a time series and estimating the age-independent LTR that most closely matched its central stochastic forecast (CIA paper section 6). This is a very data-driven method. The CMI chooses not to set an LTR.   

As mentioned in the previous section, the CIA has chosen a convergence period of 30 years, placing more reliance on recent data. In contrast, the CMI’s often shorter convergence period and zero DT may mean the LTR is a more material parameter for this model. 

Treatment of ages 90+

Both models use the APCI model to fit a range of ages. The CIA fits ages 40 to 90 and the CMI fits ages 20 to 100. To extend the model to older ages, an extrapolation is needed. The CMI fits ages up to 120 by linearly extrapolating mortality rates based on the age 99 and age 100 rates. The CIA takes a different approach. It obtained access to older age administrative datasets and used these to identify a mortality plateau in the data. It then used Hermite splines to model mortality from age 90 to the mortality plateau of 113/112 for males/females.  

The waterfall chart suggests the CIA approach leads to higher mortality improvement rates than the CMI approach. This will become more material for life expectancies at older ages.  

Conclusion

This analysis has demonstrated that different implementations of a similar mortality projection model (APCI in this case) can lead to materially different results. A multitude of models exist, and each would most likely produce a different answer. When factoring in potential model adjustments – for example, to tailor the projection to an insured population or to reflect future drivers of mortality improvement – the interval of possibilities becomes even wider. Future mortality improvement comes with a high level of uncertainty, and for that reason it may be one of the most challenging assumptions for an actuary to determine.   


More Like This...

Meet the Authors & Experts

Thomas Honeywell, Longevity Research Actuary
Author
Thomas Honeywell
Longevity Research Actuary
Annie Girard, AVP Underwriting Research
Author
Annie Girard
Assistant Vice President, Underwriting Research

References

  1. https://www.cia-ica.ca/publications/224043e/
  2. https://www.actuaries.org.uk/learn-and-develop/continuous-mortality-investigation/cmi-working-papers/mortality-projections/cmi-working-paper-129